<VariationArchive VariationID="2845241" VariationName="NM_002485.5(NBN):c.269del (p.Thr90fs)" VariationType="Deletion" Accession="VCV002845241" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3014696" VariationID="2845241">
      <GeneList>
        <Gene Symbol="NBN" FullName="nibrin" GeneID="4683" HGNC_ID="HGNC:7652" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="89933331" stop="89984667" display_start="89933331" display_stop="89984667" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="90945563" stop="90996898" display_start="90945563" display_stop="90996898" Strand="-" />
          </Location>
          <OMIM>602667</OMIM>
          <Haploinsufficiency last_evaluated="2020-08-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NBN">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-08-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NBN">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002485.5(NBN):c.269del (p.Thr90fs)</Name>
      <CanonicalSPDI>NC_000008.11:89981425:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="89981426" stop="89981426" display_start="89981426" display_stop="89981426" variantLength="1" positionVCF="89981425" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="90993654" stop="90993654" display_start="90993654" display_stop="90993654" variantLength="1" positionVCF="90993653" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>T8fs</ProteinChange>
      <ProteinChange>T90fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_158" sequenceAccession="LRG_158">
            <Expression>LRG_158:g.8246del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_158t1" sequenceAccession="LRG_158t1">
            <Expression>LRG_158t1:c.269del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_158p1" sequenceAccession="LRG_158p1" change="p.Thr90Ilefs">
            <Expression>LRG_158p1:p.Thr90Ilefs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.90993654del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.90993654del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.89981426del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.89981426del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008860.1" sequenceAccession="NG_008860" sequenceVersion="1" change="g.8246del">
            <Expression>NG_008860.1:g.8246del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024688.3" sequenceAccession="NM_001024688" sequenceVersion="3" change="c.23del">
            <Expression>NM_001024688.3:c.23del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001019859.1" sequenceAccession="NP_001019859" sequenceVersion="1" change="p.Thr8fs">
            <Expression>NP_001019859.1:p.Thr8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002485.5" sequenceAccession="NM_002485" sequenceVersion="5" change="c.269del" MANESelect="true">
            <Expression>NM_002485.5:c.269del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002476.2" sequenceAccession="NP_002476" sequenceVersion="2" change="p.Thr90fs">
            <Expression>NP_002476.2:p.Thr90fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002485.5(NBN):c.269del (p.Thr90fs) AND Microcephaly, normal intelligence and immunodeficiency" Accession="RCV003617376" Version="1">
        <ClassifiedConditionList TraitSetID="1916">
          <ClassifiedCondition DB="MedGen" ID="C0398791">Microcephaly, normal intelligence and immunodeficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16415040</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9590180</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1916" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3184" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Berlin Breakage syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microcephaly with normal intelligence immunodeficiency and lymphoreticular malignancies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonsyndromal microcephaly autosomal recessive with normal intelligence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Seemanova syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Microcephaly, normal intelligence and immunodeficiency</ElementValue>
                <XRef ID="Microcephaly+with+normal+intelligence%2C+immunodeficiency/4760" DB="Genetic Alliance" />
                <XRef ID="234638009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nijmegen breakage syndrome</ElementValue>
                <XRef ID="MONDO:0009623" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY, MICROCEPHALY, AND CHROMOSOMAL INSTABILITY</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SEEMANOVA SYNDROME II</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency, microcephaly with normal intelligence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia telangiectasia variant V1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BBS</ElementValue>
                <XRef ID="251260" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AT-V1</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NBS</ElementValue>
                <XRef Type="MIM" ID="251260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Nijmegen breakage syndrome (NBS) is characterized by progressive microcephaly, early growth deficiency that improves with age, recurrent respiratory infections, an increased risk for malignancy (primarily lymphoma), and premature ovarian failure in females. Developmental milestones are attained at the usual time during the first year; however, borderline delays in development and hyperactivity may be observed in early childhood. Intellectual abilities tend to decline over time. Recurrent pneumonia and bronchitis may result in respiratory failure and early death. Other reported malignancies include solid tumors (e.g., medulloblastoma, glioma, rhabdomyosarcoma).</Attribute>
                <XRef ID="NBK1176" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3904" />
                <XRef ID="3904" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301355</ID>
                <ID Source="BookShelf">NBK1176</ID>
              </Citation>
              <XRef ID="647" DB="Orphanet" />
              <XRef ID="C0398791" DB="MedGen" />
              <XRef ID="MONDO:0009623" DB="MONDO" />
              <XRef Type="MIM" ID="251260" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8294577" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="18665017|MedGen:C0398791" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004502864" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9590180</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16415040</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with NBN-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr90Ilefs*2) in the NBN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NBN are known to be pathogenic (PMID: 9590180, 16415040).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NBN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.90993654del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0398791" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8294577" TraitType="Disease" MappingType="XRef" MappingValue="C0398791" MappingRef="MedGen">
        <MedGen CUI="C0398791" Name="Microcephaly, normal intelligence and immunodeficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

